课题基金 / 基金详情

NOVAL HUMAN MACROPHAGE RECEPTOR

NOVAL HUMAN MACROPHAGE RECEPTOR
新型人类巨噬细胞受体
批准号:
6111213
负责人:
JUAN M SAAVEDRA
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

JUAN M SAAVEDRA的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We have found that human and rat macrophages express a novel receptor detected by binding of [125I]-CGP 4221, a compound previously considered selective for the Angiotensin II AT-2 receptor subtype. However, Angiotensin II does not recognize the novel receptor. Expression of the CGP 42112 receptor occurs after brain lesions and neuronal death in reat, and in circulating human monocytes and macrophages. Culture of human macrophages with CGP 42112 results in inhibition of production of pro-inflammatory cytokines and secretion of metalloprotein. We are continuing our efforts to clone the novel macrophage receptor form cDNA libraries obtained from human monocytes and from rat spleen.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Brain pathophysiology in SARS-CoV-2 disease
  • 批准号:
    10317394
  • 项目类别:
  • 资助金额:
    $66.15万
  • 财政年份:
    2021
  • 负责人:
    JUAN M SAAVEDRA
  • 依托单位:
Brain pathophysiology in SARS-CoV-2 disease
  • 批准号:
    10617754
  • 项目类别:
  • 资助金额:
    $62.36万
  • 财政年份:
    2021
  • 负责人:
    JUAN M SAAVEDRA
  • 依托单位:
Brain pathophysiology in SARS-CoV-2 disease
  • 批准号:
    10434951
  • 项目类别:
  • 资助金额:
    $63.05万
  • 财政年份:
    2021
  • 负责人:
    JUAN M SAAVEDRA
  • 依托单位:
Mechanistic studies on stress, brain inflammation and neuroprotection